The Combined Effect of N-Acetyl Cysteine and Metformin in Polycystic Ovary Syndrome Patients

PHASE3RecruitingINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

February 1, 2026

Study Completion Date

May 1, 2026

Conditions
Polycystic Ovary Syndrome
Interventions
DRUG

N-acetyl cysteine

N-Acetyl Cysteine (NAC) has antioxidant properties and is essential for the body's production of glutathione, and both glutathione and NAC are potent antioxidants.

DRUG

Metfomin

metformin is commonly used for managing polycystic ovary syndrome (PCOS) due to its benefits in addressing several underlying features of the condition. While it is not officially approved by regulatory agencies like the FDA for PCOS, it is widely recognized and recommended in clinical practice guidelines as an off-label treatment for PCOS, particularly in women with insulin resistance and metabolic dysfunction.

Trial Locations (1)

Unknown

RECRUITING

Kasr El-Ainy hospital, Cairo

All Listed Sponsors
lead

Cairo University

OTHER